Apax Partners in talks to buy Israel's Syneron Medical -report

JERUSALEM, Feb 13 (Reuters) - British private equity fund Apax Partners is in talks to buy Israel-based Syneron Medical , an aesthetic device company, for $350-$400 million, Israeli financial daily Calcalist reported on Monday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.